Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease.
暂无分享,去创建一个
G. Hindricks | J. Gummert | J. Garbade | H. Kottkamp | A. Boldt | S. Dhein | U. Wetzel | J. Lauschke | J. Weigl
[1] Arantxa González,et al. Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? , 2002, Journal of molecular and cellular cardiology.
[2] Gerhard Hindricks,et al. Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques. , 2002, Journal of the American College of Cardiology.
[3] E. Bernal,et al. Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.
[4] Claus Schmitt,et al. Characterization of Paroxysmal and Persistent Atrial Fibrillation in the Human Left Atrium During Initiation and Sustained Episodes , 2002, Journal of cardiovascular electrophysiology.
[5] Zoltan Szalay,et al. Structural correlate of atrial fibrillation in human patients. , 2002, Cardiovascular research.
[6] M. Allessie,et al. Electrical, contractile and structural remodeling during atrial fibrillation. , 2002, Cardiovascular research.
[7] Stanley Nattel,et al. Cellular electrophysiology of atrial fibrillation. , 2002, Cardiovascular research.
[8] A. Goette,et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. , 2002, Cardiovascular research.
[9] Harry J G M Crijns,et al. Molecular mechanisms of remodeling in human atrial fibrillation. , 2002, Cardiovascular research.
[10] S. Nattel,et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.
[11] H. Jongsma,et al. Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. , 2002, Cardiovascular research.
[12] S. Nattel. New ideas about atrial fibrillation 50 years on , 2002, Nature.
[13] S. Dhein,et al. Chronic effects of endothelin‐1 and angiotensin‐II on gap junctions and intercellular communication in cardiac cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] S. Nattel,et al. Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.
[15] H. Crijns,et al. Endothelin System in Human Persistent and Paroxysmal Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.
[16] L. Opie,et al. Enhanced Angiotensin II Activity in Heart Failure: Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes , 2001, Circulation research.
[17] K G Shyu,et al. Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes. , 2001, Journal of molecular and cellular cardiology.
[18] Michael R. Rosen,et al. Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.
[19] U Schotten,et al. Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial Fibrillation , 2001, Circulation.
[20] Y. Takagishi,et al. Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade. , 2001, Journal of molecular and cellular cardiology.
[21] E J Berbari,et al. Differences in organization between acute and chronic atrial fibrillation in dogs. , 2000, Journal of the American College of Cardiology.
[22] A. Goette,et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.
[23] KikuoArakawa,et al. Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation , 2000 .
[24] M. Allessie,et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. , 2000, Cardiovascular research.
[25] A. Goette,et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.
[26] W. Hsueh,et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. , 2000, Circulation.
[27] 李永军,et al. Atrial Fibrillation , 1999 .
[28] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.
[29] HiroakiMatsubara. Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases , 1998 .
[30] M. B. Perryman,et al. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart. , 1998, Circulation.
[31] Y. Niho,et al. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. , 1998, Hypertension.
[32] M. Allessie,et al. Altered Pattern of Connexin40 Distribution in Persistent Atrial Fibrillation in the Goat , 1998, Journal of cardiovascular electrophysiology.
[33] C. Lau,et al. Relation between mitral regurgitation and platelet activation. , 1997, Journal of the American College of Cardiology.
[34] D. Zipes,et al. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. , 1997, Circulation.
[35] M. B. Perryman,et al. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. , 1997, Circulation.
[36] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[37] J. Sadoshima,et al. Critical Role of the AT1 Receptor Subtype , 2005 .
[38] J. Marrugat,et al. A prospective study of atrial fibrillation and stroke. , 1989, Stroke.
[39] J. Waktare,et al. ATRIAL fibrillation. , 2002, The Heart bulletin.